Adiponectin predicts insulin resistance but not endothelial function in young, healthy adolescents

Journal of Clinical Endocrinology and Metabolism

Volumn 90, Issue 8, 2005, Pages 4615-4621

  Singhal, Atul ^a   Jamieson, Nigel ^b   Fewtrell, Mary ^a   Deanfield, John ^a   Lucas, Alan ^a   Sattar, Naveed ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b GLASGOW ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN; GLUCOSE; HORMONE; INSULIN;

ADOLESCENT; ARTERIOGRAPHY; ARTERY BLOOD FLOW; ARTERY DILATATION; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; BODY FAT; BRACHIAL ARTERY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; ENDOTHELIUM; FEMALE; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; HORMONE ACTION; HORMONE BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID ANALYSIS; MALE; OBESITY; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RADIOIMMUNOASSAY; RISK REDUCTION;

ADIPONECTIN; ADOLESCENT; BIOLOGICAL MARKERS; BODY WEIGHT; BRACHIAL ARTERY; CARDIOVASCULAR DISEASES; ELECTRIC IMPEDANCE; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; INSULIN RESISTANCE; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; PREDICTIVE VALUE OF TESTS; REFERENCE VALUES; REGIONAL BLOOD FLOW; RISK FACTORS;

EID: 23844551198     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2005-0131     Document Type: Article

References (46)

1. Must A, Jacques PF, Dallal GE, Bajema CJ, Dietz WH 1992 Long-term morbidity and mortality of overweight adolescents: a follow-up of the Harvard Growth Study of 1922 to 1935. N Engl J Med 327:1350-1355
2. Tounian P, Aggoun Y, Dubern B, Varille V, Guy-Grand B, Sidi D, Girardet JP, Bonnet D 2001 Presence of increased stiffness of the common carotid artery and endothelial dysfunction in severely obese children: a prospective study. Lancet 358:1400-1404
3. Steinberg HO, Chaker H, Leaming R, Johnson A, Brechtel G, Baron AD 1996 Obesity/insulin resistance is associated with endothelial dysfunction: implications for the syndrome of insulin resistance. J Clin Invest 97:2601-2610
4. Raitakari M, Ilvonen T, Ahotupa M, Lehtimaki T, Harmoinen A, Suominen P, Elo J, Hartiala J, Raitakari OT 2004 Weight reduction with very low calorie diet and endothelial function in overweight adults: role of plasma glucose. Arterioscler Thromb Vasc Biol 24:124-128
5. Ross R 1993 The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362:801-809
6. Schachinger V, Britten MB, Zeiher AM 2000 Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation 101:1899-1906
7. Goldstein BJ, Scalia R 2004 Adiponectin: a novel adipokine linking adipocytes and vascular function. J Clin Endocrinol Metab 89:2563-2568
8. Spranger J, Kroke A, Mohlig M, Bergmann MM, Ristow M, Boeing H, Pfeiffer AFH 2003 Adiponectin and protection against type 2 diabetes mellitus. Lancet 361:226-228
9. Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, Hara K, Mori Y, Ide T, Murakami K, Tsuboyama-Kasaoka N, Ezaki O, Akanuma Y, Gavrilova O, Vinson C, Reitman ML, Kagechika H, Shudo K, Yoda M, Nakano Y, Tobe K, Nagai K, Kimura S, Tomita M, Froguel P, Kadowaki T 2001 The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 7:941-946
10. Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, Hotta K, Shimomura I, Nakamura T, Miyaoka K, Kuriyama H, Nishida M, Yamashita S, Okubo K, Matsubara K, Muraguchi M, Ohmoto Y, Funahashi T, Matsuzawa Y 1999 Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 257:79-83
11. Yamamoto Y, Hirose H, Saito I, Tomita M, Taniyama M, Matsubara K, Okazaki Y, Ishii T, Nishikai K, Saruta T 2002 Correlation of the adipocyte-derived protein adiponectin with insulin resistance index and serum high-density lipoprotein-cholesterol, independent of body mass index, in the Japanese population. Clin Sci 103:137-142
12. Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE, Tataranni PA 2001 Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 86:1930-1935
13. Kumada M, Kihara S, Sumitsuji S, Kawamoto T, Matsumoto S, Ouchi N, Arita Y, Okamoto Y, Shimomura I, Hiraoka H, Nakamura T, Funahashi T, Matsuzawa Y 2003 Association of hypoadiponectinemia with coronary artery disease in men. Arterioscler Thromb Vasc Biol 23:85-89
14. Pischon T, Girman CJ, Hotamisligil GS, Rifai N, Hu FB, Rimm EB 2004 Plasma adiponectin levels and risk of myocardial infarction in men. JAMA 291:1730-1737
15. Ouchi N, Kihara S, Arita Y, Maeda K, Kuriyama H, Okamoto Y, Hotta K, Nishida M, Takahashi M, Nakamura T, Yamashita S, Funahashi T, Matsuzawa Y 1999 Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation 100:2473-2476
16. Ouchi N, Kihara S, Arita Y, Nishida M, Matsuyama A, Okamoto Y, Ishigami M, Kuriyama H, Kishida K, Nishizawa H, Hotta K, Muraguchi M, Ohmoto Y, Yamashita S, Funahashi T, Matsuzawa Y 2001 Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages. Circulation 103:1057-1063
17. Matsuda M, Shimomura I, Sata M, Arita Y, Nishida M, Maeda N, Kumada M, Okamoto Y, Nagaretani H, Nishizawa H, Kishida K, Komuro R, Ouchi N, Kihara S, Nagai R, Funahashi T, Matsuzawa Y 2002 Role of adiponectin in preventing vascular stenosis; the missing link of adipo-vascular axis. J Biol Chem 277:37487-37491
18. Chen H, Montagnani M, Funahashi T, Shimomura I, Quon MJ 2003 Adiponectin stimulates production of nitric oxide in vascular endothelial cells. J Biol Chem 278:45021-45026
19. Ouchi N, Ohishi M, Kihara S, Funahashi T, Nakamura T, Nagaretani H, Kumada M, Ohashi K, Okamoto Y, Nishizawa H, Kishida K, Maeda N, Nagasawa A, Kobayashi H, Hiraoka H, Komai N, Kaibe M, Rakugi H, Ogihara T, Matsuzawa Y 2003 Association of hypoadiponectinemia with impaired vasoreactivity. Hypertension 42:231-234
20. Okamoto Y, Kihara S, Ouchi N, Nishida M, Arita Y, Kumada M, Ohashi K, Sakai N, Shimomura I, Kobayashi H, Terasaka N, Inaba T, Funahashi T, Matsuzawa Y 2002 Adiponectin reduces atherosclerosis in apolipoprotein E-deficient mice. Circulation 106:2767-2770
21. Tan KCB, Xu A, Chow WS, Lam MCW, AI VHG, Tam SCF, Lam KSL 2004 Hypoadiponectinemia is associated with impaired endothelium-dependent vasodilation. J Clin Endocrinol Metab 89:765-769
22. Shimabukuro M, Higa N, Asahi T, Oshiro Y, Takasu N, Tagawa T, Ueda S, Shimomura I, Funahashi T, Matsuzawa Y 2003 Hypoadiponectinemia is closely linked to endothelial dysfunction in man. J Clin Endocrinol Metab 88:3236-3240
23. Fernandez-Real JM, Lopez-Bermejo A, Castro A, Penarroja G, Vazquez G, Ricart W, Casamitjana R 2004 Adiponectin is associated with vascular function independent of insulin sensitivity. Diabetes Care 27:739-745
24. Singhal A, Kattenhorn M, Cole TJ, Deanfield J, Lucas A 2001 Preterm birth, vascular function, and risk factors for atherosclerosis. Lancet 358:1159-1160
25. Singhal A, Farooqi S, Cole TJ, O'Rahilly S, Fewtrell M, Kattenhorn M, Lucas A, Deanfield J 2002 Influence of leptin on arterial distensibility; a novel link between obesity and cardiovascular disease. Circulation 106:1919-1924
26. Leeson CPM, Whincup PH, Cook DG, Donald AE, Papacosta O, Lucas A, Deanfield JE 1997 Flow-mediated dilation in 9- to 11-year-old children. The influence of intrauterine and childhood factors. Circulation 96:2233-2238
27. Leeson CPM, Whincup PH, Cook DG, Mullen MJ, Donald AE, Seymour CA, Deanfield JE 2000 Cholesterol and arterial distensibility in the first decade of life: a population-based study. Circulation 101:1533-1538
28. Schaefer F, Georgi M, Zieger A, Scharer K 1994 Usefulness of bioelectric impedance and skinfold measurements in predicting fat-free mass derived from total body potassium in children. Pediatr Res 35:617-624
29. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC 1985 Homeostasis model assessment: insulin resistance and β -cell function from fasting glucose and insulin concentrations in man. Diabetologia 28:412-419
30. e scale simplify the presentation of log transformed data. Stat Med 19:3109-3125
31. Nemet D, Wang P, Funahashi T, Matsuzawa Y, Tanaka S, Engelman L, Cooper DM 2003 Adipocytokines, body composition, and fitness in children. Pediatr Res 53:148-152
32. Cruz M, Medina-Navarro R, Garcia-Macedo R, Duran G, Garcia-Valerio Y, Wacher N, Gutierrez M, Kumate J 2004 Low adiponectin levels predict type 2 diabetes in Mexican Children. Diabetes Care 27:1451-1453
33. Reinehr T, Roth C, Menke T, Andler W 2004 Adiponectin before and after weight loss in obese children. J Clin Endocrinol Metab 89:3790-3794
34. Stefan N, Bunt JC, Salbe AD, Funahashi T, Matsuzawa Y, Tataranni PA 2002 Plasma adiponectin concentrations in children: relationships with obesity and insulinemia. J Clin Endocrinol Metab 87:4652-4656
35. Huang KC, Lue BH, Yen RF, Shen CG, Ho SR, Tai TY, Yang WS 2004 Plasma adiponectin levels and metabolic factors in nondiabetic adolescents. Obes Res 12:119-124
36. Soderberg S, Stegmayr B, Stenlund H, Sjostrom LG, Agren A, Johansson L, Weinehall L, Olsson T 2004 Leptin, but not adiponectin, predicts stroke in males. J Intern Med 256:128-136
37. Gungor N, Saad R, Janosky J, Arslanian S 2004 Validation of surrogate estimates of insulin sensitivity and insulin secretion in children and adolescents. J Pediatr 144:47-55
38. Slyper AH 2004 Clinical Review 168: What vascular ultrasound testing has revealed about pediatric atherogenesis, and a potential clinical role for ultrasound in pediatric risk assessment. J Clin Endocrinol Metab 89:3089-3095
39. Mullen MJ, Thorne SA, Deanfield JE 1997 Noninvasive assessment of endothelial function. Heart 4:297-298
40. Yamauchi T, Kamon J, Ito Y, Tsuchida A, Yokomizo T, Kita S, Sugiyama T, Miyagishi M, Hara K, Tsunoda M, Murakami K, Ohteki T, Uchida S, Takekawa S, Waki H, Tsuno NH, Shibata Y, Terauchi Y, Froguel P, Tobe K, Koyasu S, Taira K, Kitamura T, Shimizu T, Nagal R, Kadowaki T 2003 Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 423:762-769
41. Maeda N Shimomura I, Kishida K, Nishizawa H, Matsuda M, Nagaretani H, Furuyama N, Kondo H, Takahashi M, Arita Y, Komuro R, Ouchi N, Kihara S, Tochino Y, Okutomi K, Horie M, Takeda S, Aoyama T, Funahashi T, Matsuzawa Y 2002 Diet-induced insulin resistance in mice lacking adiponectin/ ACRP30. Nat Med 8:731-737
42. Vionnet N, Hani EH, Dupont S, Gallina S, Francke S, Dotte S, DeMatos F, Durand E, Lepretre F, Lecoeur C, Gallina P, Zekiri L, Dina C, Froguel P 2000 Genomewide search for type 2 diabetes-susceptibility genes in French whites: evidence for a novel susceptibility locus for early-onset diabetes on chromosome 3q27-qter and independent replication of a type 2-diabetes locus on chromosome 1q21-q24. Am J Hum Genet 67:1470-1480
43. Statnick MA, Beavers LS, Conner LJ, Corominola H, Johnson D, Hammond CD, Rafaeloff-Phail R, Seng T, Suter TM, Sluka JP, Ravussin E, Gadski RA, Caro JF 2000 Decreased expression of apM1 in omental and subcutaneous adipose tissue of humans with type 2 diabetes. Int J Exp Diabetes Res 1:81-88
44. Weiss R, Dufour S, Taksali SE, Tamborlane WV, Petersen KF, Bonadonna RC, Boselli L, Barbetta G, Allen K, Rife F, Savoye M, Dziura J, Sherwin R, Shulman GI, Caprio S 2003 Prediabetes in obese youth: a syndrome of impaired glucose tolerance, severe insulin resistance, and altered myocellular and abdominal fat partitioning. Lancet 362:951-957
45. Vanhala M, Vanhala P, Kumpusalo E, Halonen P, Takala J 1998 Relation between obesity from childhood to adulthood and the metabolic syndrome: population based study. BMJ 317:319
46. Lindsay RS, Funahashi T, Hanson RL, Matsuzawa Y, Tanaka S, Tataranni PA, Knowler WC, Krakoff J 2002 Adiponectin and the development of type 2 diabetes in the Pima Indian population. Lancet 360:57-58